Abstract
Background
Early surgery has been consistently demonstrated to reduce complications and mortality in hip fracture patients. There remains no general consensus, however, regarding the optimal time to surgery for hip fracture patients who are on novel oral anticoagulants (NOAC) on admission and its effect on clinical outcomes after surgery. The objective of this review was to assess the effect of preoperative NOAC therapy on time to surgery and postoperative complications in hip fracture patients.
Methods
We performed a systematic review of the literature using the PubMed, Embase, and Cochrane Library electronic databases. Relevant articles were identified and included if they: (i) included patients on NOAC therapy on admission who did not undergo reversal; (ii) included a control group of patients not on any anticoagulation; (iii) included time from admission to surgery; and (iv) included one of the following outcomes: blood transfusion, venous thromboembolism (VTE), stroke, readmission, and mortality.
Results
Nine studies were included with a total of 4,419 patients. There were 414 NOAC patients and 4,005 non-anticoagulated patients. Six of the nine studies found a significant increase in time to surgery for patients on NOAC therapy. Three of the seven studies that reported rates of blood transfusion found a significantly higher incidence of transfusion in patients on NOACs. None of the studies found a significant difference in VTE and stroke. One of the two studies that reported readmissions showed a higher risk of readmission for patients on NOACs. Eight of the nine included studies found no significant difference in postoperative mortality rates between the NOAC and control groups, with the remaining study finding a higher mortality rate only in patients on NOAC therapy who underwent fixation and not those who underwent arthroplasty.
Conclusions
These mixed findings suggest that delay to surgery may not be warranted in the urgent surgical setting of patients on NOAC therapy who sustain hip fractures.
Similar content being viewed by others
References
Gullberg B, Johnell O, Kanis JA (1997) World-wide projections for hip fracture. Osteoporos Int 7(5):407–413
Leibson CL, Tosteson AN, Gabriel SE, Ransom JE, Melton LJ (2002) Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study. J Am Geriatr Soc 50(10):1644–1650
Cooper C (1997) The crippling consequences of fractures and their impact on quality of life. Am J Med 103(2A):12S-17S
Ftouh S, Morga A, Swift C, Guideline Development Group (2011) Management of hip fracture in adults: summary of NICE guidance. BMJ. https://doi.org/10.1136/bmj.d3304
Khan SK, Kalra S, Khanna A, Thiruvengada MM, Parker MJ (2009) Timing of surgery for hip fractures: a systematic review of 52 published studies involving 291,413 patients. Injury 40(7):692–697
Ryan DJ, Yoshihara H, Yoneoka D, Egol KA, Zuckerman JD (2015) Delay in hip fracture surgery: an analysis of patient-specific and hospital-specific risk factors. J Orthop Trauma 29(8):343–348
Lawrence JE, Fountain DM, Cundall-Curry DJ, Carrothers AD (2017) Do patients taking warfarin experience delays to theatre, longer hospital stay, and poorer survival after hip fracture? Clin Orthop Relat Res 475(1):273–279
Tran T, Delluc A, de Wit C, Petrcich W, Le Gal G, Carrier M (2015) The impact of oral anticoagulation on time to surgery in patients hospitalized with hip fracture. Thromb Res 136(5):962–965
Barnes GD, Lucas E, Alexander GC, Goldberger ZD (2015) National trends in ambulatory oral anticoagulant use. Am J Med 128(12):1300–1305
Collinge CA, Kelly KC, Little B, Weaver T, Schuster RD (2012) The effects of clopidogrel (Plavix) and other oral anticoagulants on early hip fracture surgery. J Orthop Trauma 26(10):568–573
Franklin NA, Ali AH, Hurley RK, Mir HR, Beltran MJ (2018) Outcomes of early surgical intervention in geriatric proximal femur fractures among patients receiving direct oral anticoagulation. J Orthop Trauma 32(6):269–273
Mullins B, Akehurst H, Slattery D, Chesser T (2018) Should surgery be delayed in patients taking direct oral anticoagulants who suffer a hip fracture? A retrospective, case-controlled observational study at a UK major trauma centre. BMJ Open 8(4):e020625
Frenkel Rutenberg T, Velkes S, Vitenberg M, Leader A, Halavy Y, Raanani P et al (2018) Morbidity and mortality after fragility hip fracture surgery in patients receiving vitamin K antagonists and direct oral anticoagulants. Thromb Res 166:106–112
Bruckbauer M, Prexl O, Voelckel W, Ziegler B, Grottke O, Maegele M et al (2019) Impact of direct oral anticoagulants in patients with hip fractures. J Orthop Trauma 33(1):e8-13
Schermann H, Gurel R, Gold A, Maman E, Dolkart O, Steinberg EL et al (2019) Safety of urgent hip fracture surgery protocol under influence of direct oral anticoagulation medications. Injury 50(2):398–402
Hourston GJ, Barrett MP, Khan WS, Vindlacheruvu M, McDonnell SM (2019) New drug, new problem: do hip fracture patients taking NOACs experience delayed surgery, longer hospital stay, or poorer outcomes? Hip Int 25:1120700019841351
Schuetze K, Eickhoff A, Dehner C, Gebhard F, Richter PH (2019) Impact of oral anticoagulation on proximal femur fractures treated within 24h—a retrospective chart review. Injury 50(11):2040–2044
Cafaro T, Simard C, Tagalakis V, Koolian M, Network CanVECTOR (2019) Delayed time to emergency hip surgery in patients taking oral anticoagulants. Thromb Res 184:110–114
Cohn MR, Levack AE, Trivedi NN, Villa JC, Wellman DS, Lyden JP et al (2017) The hip fracture patient on warfarin: evaluating blood loss and time to surgery. J Orthop Trauma 31(8):407–413
Martin DT, Barton CA, Dodgion C, Schreiber M (2016) Emergent reversal of vitamin K antagonists: addressing all the factors. Am J Surg 211(5):919–925
Mattisson L, Lapidus LJ, Enocson A (2018) Is fast reversal and early surgery (within 24 h) in patients on warfarin medication with trochanteric hip fractures safe? A case-control study. BMC Musculoskelet Disord 19(1):203
Moores TS, Chatterton BD, Walker MJ, Roberts PJ (2018) Standardised warfarin reversal expedites time to theatre for fractured neck of femur surgery and improves mortality rates: a matched cohort study. Adv Orthop 21:4791214
Meinig R, Jarvis S, Orlando A, Nwafo N, Banerjee R, McNair P et al (2020) Is anticoagulation reversal necessary prior to surgical treatment of geriatric hip fractures? J Clin Orthop Trauma 11(Suppl 1):S93–S99
Yoo MS, Zhu S, Jiang SF, Hammer HL, McBride WJ, McCarthy CM et al (2020) Association of reversal of anticoagulation preoperatively on 30-day mortality and outcomes for hip fracture surgery. Am J Med. https://doi.org/10.1016/j.amjmed.2020.01.002
Cuker A, Burnett A, Triller D, Crowther M, Ansell J, Van Cott EM et al (2019) Reversal of direct oral anticoagulants: guidance from the anticoagulation forum. Am J Hematol 94(6):697–709
Caruso G, Andreotti M, Marko T, Tonon F, Corradi N, Rizzalo D et al (2019) The impact of warfarin on operative delay and 1-year mortality in elderly patients hip hip fracture: a retrospective observational study. J Orthop Surg Res 14(1):169
Funding
There is no funding source.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. Forsh has financial relationships with Stryker (paid consultant). None of the other authors have any financial interests or affiliations with institutions, organizations, or companies relevant to the manuscript. None of the authors received payment or funding support in kind for any aspect of the submitted work.
Institutional Review Board Approval
IRB approval was not required for the submitted work at our institution.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Cheung, Z.B., Xiao, R. & Forsh, D.A. Time to surgery and complications in hip fracture patients on novel oral anticoagulants: a systematic review. Arch Orthop Trauma Surg 142, 633–640 (2022). https://doi.org/10.1007/s00402-020-03701-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00402-020-03701-2